Logo-BCC-Research.jpg
Antibody Drug Market Expected to Gain $30 Billion Through 2022
03. Oktober 2017 14:30 ET | BCC Research
WELLESLEY, Mass. , Oct. 03, 2017 (GLOBE NEWSWIRE) -- An increase in research and development, burgeoning industry competition and evolving technologies are steering the antibody drug market into a...
AbCellera Completes
AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates
24. August 2016 09:00 ET | AbCellera
VANCOUVER, British Columbia, Aug. 24, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...